Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19-Reference-Cited by-同舟云学术

Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19

Published:2021-06 Issue: Volume:88 Page:52-62
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Dalekos George N.,Stefos Aggelos^ORCID,Georgiadou Sarah,Lygoura Vasiliki,Michail Anastasia,Ntaios George,Samakidou Anna^ORCID,Giannoulis George,Gabeta Stella,Vlychou Marianna,Petinaki Efthymia,Leventogiannis Konstantinos,Giamarellos-Bourboulis Evangelos J.,Gatselis Nikolaos K.

Publisher

Elsevier BV

Subject

Internal Medicine

Reference52 articles.

1. Complex immune dysregulation in COVID-19 patients with severe respiratory failure;Giamarellos-Bourboulis;Cell Host Microbe,2020

2. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies;Conti;J Biol Regul Homeost Agents,2020

3. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China;Ruan;Intensive Care Med,2020

4. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020

5. An inflammatory cytokine signature predicts COVID-19 severity and survival;Del Valle;Nat Med,2020

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osteonecrosis risk after steroids-related treatment of COVID-19 is not negligible: A cross sectional study;European Journal of Internal Medicine;2024-01

2. Calprotectin serum levels on admission and during follow-up predict severity and outcome of patients with COVID-19: A prospective study;European Journal of Internal Medicine;2023-11

3. Immune regulators for the treatment of COVID-19: A critical appraisal after two years;European Journal of Internal Medicine;2023-10

4. Innate Immune Gene Polymorphisms and COVID-19 Prognosis;Viruses;2023-08-22

5. Evaluation of anakinra in the management of patients with COVID-19 infection: A randomized clinical trial;Frontiers in Microbiology;2023-01-26